AVAIL Vapor, LLC, a leading premium e-liquid manufacturing, regulatory and scientific services and retail business, today announced its entry into nine major brand FDA regulatory contracts. As a result, AVAIL will lead the submission of an array of products for the FDA’s premarket tobacco product application (“PMTA”) process, submitting the first of those applications in early in 2020 and completing the portfolio before the May 2020 deadline. “We are thrilled these major brands are placing their trust in us as we move forward together to provide leadership in raising the standards of our industry to help build trust in our products,” AVAIL COO Russ Rogers said in the news release. “We have spent significant time, focus and energy in building our regulatory, ISO 17205 analytical lab, and manufacturing teams to position our company for success with regard to the FDA’s public health expectations. Collaborating with great U.S. e-liquid companies and international device manufacturers on such a critical initiative as PMTAs will validate the value AVAIL can add in ensuring the appropriateness of these products on the market. Ensuring the highest-quality standards in the ENDS and CBD industries is at the forefront of our mission.”
To view the full press release, visit http://cnw.fm/IrcL4
Richmond, Virginia-based AVAIL is the leading premium U.S. e-liquid and CBD manufacturer, retailer and provider of industry scientific and regulatory services. The company delivers on the promise of quality across its customer base through: retail, sciences and regulatory, manufacturing, and research & development. AVAIL retail offers a broad array of products online and in its 99 stores across 12 states. The regulatory services division promotes turnkey regulatory and scientific services to customers across the industry. Information on AVAIL products is available through retail stores and on the web at www.AVAILVapor.com.
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire is part of the InvestorBrandNetwork.